Trulieve CPO granted options and RSUs

Trulieve Cannabis Corp. Chief Production Officer Kyle Landrum received new equity awards as compensation.

Rhea-AI Filing Summary

Trulieve Cannabis Corp. Chief Production Officer Kyle Landrum received new equity awards as compensation. He was granted options to buy 41,668 subordinate voting shares at an exercise price of $6.40 per share, expiring on March 13, 2033. These options vest in three equal annual installments on December 1, 2026, December 1, 2027, and December 1, 2028.

Landrum also received 58,594 restricted stock units, each representing one subordinate voting share. Half of these RSUs vest on December 1, 2027 and the remaining half on December 1, 2028. Following the RSU grant, he directly owns 258,776 subordinate voting shares.

Insider Trade Summary

Grant/Award: 100,262 shares

Grant/Award 2 txns

Insider Landrum Kyle

Role Chief Production Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	41,668	$0.00	$0.00
Grant/Award	Subordinate Voting Shares	58,594	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 41,668 contracts (Direct); Subordinate Voting Shares — 258,776 shares (Direct)

Footnotes (2)

1. F1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028.
2. F2. The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Kyle Landrum receive in Trulieve Cannabis (TCNNF) Form 4?

Kyle Landrum received stock options for 41,668 subordinate voting shares and 58,594 restricted stock units. The options carry a $6.40 exercise price, while each RSU converts into one Trulieve subordinate voting share upon vesting under the specified schedule.

What is the vesting schedule for Kyle Landrum’s Trulieve stock options?

Landrum’s stock options vest in three equal annual installments. One-third vests on December 1, 2026, another third on December 1, 2027, and the final third on December 1, 2028, aligning with a long-term retention timeline.

When do Kyle Landrum’s Trulieve RSUs from this grant vest?

The 58,594 RSUs vest in two tranches. Half of the restricted stock units vest on December 1, 2027, and the remaining half vest on December 1, 2028, contingent on continued service or other plan conditions.

What is the exercise price and expiration date of Landrum’s Trulieve stock options?

The granted options allow Landrum to acquire shares at an exercise price of $6.40 per subordinate voting share. These options expire on March 13, 2033, giving him a long window to decide whether to exercise based on future conditions.

How many Trulieve subordinate voting shares does Kyle Landrum hold after these grants?

After the reported RSU grant, Landrum directly holds 258,776 subordinate voting shares. This figure reflects his post-transaction ownership as recorded in the Form 4 and provides context for the scale of his existing equity exposure.

Is Kyle Landrum’s Form 4 transaction a market buy or sell of Trulieve shares?

The filing reflects compensation-related grants, not open-market trades. Both the stock options and RSUs were awarded at a transaction price of $0.00 per share, meaning they were granted by the company rather than purchased or sold in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 05:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Landrum Kyle

(Last) (First) (Middle)

C/O TRULIEVE CANNABIS CORP.

3494 MARTIN HURST ROAD

(Street)

TALLAHASSEE FL 32312

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Production Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Subordinate Voting Shares	03/13/2026		A		58,594(1)	A	$0	258,776	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$6.4	03/13/2026		A		41,668		(2)	03/13/2033	Subordinate Voting Shares	41,668	$0	41,668	D

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028.

2. The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028.

	/s/ Eric Powers, as Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.